HOWARD PRATT: Open Payments
NPI 1033526785 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,520 in 76 payments from 9 companies in 2025. Trend: 2023 $525 · 2024 $1,425 · 2025 $9,520
Consulting: $5,520Food & beverage: $3,203Travel & lodging: $797
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $7,109 |
| Teva Pharmaceuticals USA, Inc. | 13 | $880 |
| Neurocrine BioSciences, Inc. | 17 | $861 |
| Janssen Pharmaceuticals, Inc | 10 | $202 |
| Alkermes, Inc. | 8 | $180 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| ABBVIE INC. | 4 | $78 |
| Janssen Scientific Affairs, LLC | 1 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: INGREZZA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, ARISTADA, UZEDY, ERZOFRI EXTENDED-RELEASE, VRAYLAR.
Industry payments across FL — which companies pay providers there.
